FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385609404> ?p ?o ?g. }

• W4385609404 endingPage "e34496" @default.
• W4385609404 startingPage "e34496" @default.
• W4385609404 abstract "Background: Endometriosis (EMT) is a benign and common estrogen-dependent disease. Hormonal therapy improves pain symptoms in most women with EMT. However, in many cases, laparoscopic fertility preservation surgery is considered a common treatment for EMT. The present study aimed to evaluate the efficacy and safety of dienogest, leuprolide, danazol, gestrinone, mifepristone and levonorgestrel intrauterine system (LNG-IUS) in relieving symptoms and delaying the recurrence of EMT cysts after fertility protection surgery. Methods: We searched PubMed, the Cochrane Library, Web of Science, EMBase, China National Knowledge Infrastructure, VIP Database, China Biology Medicine disc, WanFang Data databases to collect randomized controlled trials (RCT) related to dienogest, leuprolide, danazol, gestrinone, mifepristone and LNG-IUS as a follow-up treatment after fertility preserving surgery for EMT. After literature screening, data extraction and quality evaluation, effective rate, recurrence rate, pregnancy rate and adverse reaction rate were used as outcome indicators to evaluate the efficacy and safety of drugs. Evidence networks included in the study were drawn and publication bias was assessed. The drugs most likely to be the best postoperative treatment were explored through mixed comparison of different drugs and efficacy ranking. Result: Effective rate: dienogest, leprerelin, gestrinone and LNG-IUS were better than placebo after EMT fertility preservation surgery; dienogest was superior to mifepristone and danazol. LNG-IUS is superior to danazol. LNG-IUS has the highest potential for improving the effectiveness of EMT symptoms. Recurrence rate: the application of dienogest, leuprolide, gestrinone, mifepristone and LNG-IUS after EMT fertility preservation surgery was lower than that of placebo; dienogest and LNG-IUS were lower than danazol. The recurrence rate of dinorgestrel was the last place with the highest performance. Pregnancy rate: in the cases with fertility requirements, dienogest and,leuprolide were better than placebo after EMT fertility preservation surgery; dienogest was superior to danazol, gestrinone and mifepristone. Leuprolide is superior to danazol and gestrinone. The first rank of dienogest pregnancy rate was the highest. Adverse reaction rate: the application of dienogest, leuprolide, danazol, gestrinone, mifepristone and LNG-IUS after EMT fertility preservation surgery was higher than that of placebo. After placebo, LNG-IUS had the highest adverse reaction rate. Conclusion: For patients after fertility preserving surgery for EMT, the recurrence rate of dienogest was the last place with highest preference. The first rank of dienogest pregnancy was the highest." @default.
• W4385609404 created "2023-08-06" @default.
• W4385609404 creator A5002223340 @default.
• W4385609404 creator A5005294787 @default.
• W4385609404 creator A5016856595 @default.
• W4385609404 creator A5024283778 @default.
• W4385609404 creator A5025777565 @default.
• W4385609404 creator A5034735808 @default.
• W4385609404 creator A5069469064 @default.
• W4385609404 date "2023-08-04" @default.
• W4385609404 modified "2023-09-26" @default.
• W4385609404 title "Efficacy and safety of different subsequent therapies after fertility preserving surgery for endometriosis: A systematic review and network meta-analysis" @default.
• W4385609404 cites W1554228382 @default.
• W4385609404 cites W1977038657 @default.
• W4385609404 cites W1988814797 @default.
• W4385609404 cites W1989126575 @default.
• W4385609404 cites W2012650501 @default.
• W4385609404 cites W2021876927 @default.
• W4385609404 cites W2022191811 @default.
• W4385609404 cites W2032738770 @default.
• W4385609404 cites W2042757069 @default.
• W4385609404 cites W2049648603 @default.
• W4385609404 cites W2070996255 @default.
• W4385609404 cites W2083667580 @default.
• W4385609404 cites W2089689442 @default.
• W4385609404 cites W2098923148 @default.
• W4385609404 cites W2100586204 @default.
• W4385609404 cites W2105437500 @default.
• W4385609404 cites W2131027406 @default.
• W4385609404 cites W2142407183 @default.
• W4385609404 cites W2325235240 @default.
• W4385609404 cites W2356563851 @default.
• W4385609404 cites W2396755107 @default.
• W4385609404 cites W2398997144 @default.
• W4385609404 cites W2400254491 @default.
• W4385609404 cites W2462694618 @default.
• W4385609404 cites W2571030170 @default.
• W4385609404 cites W2588681363 @default.
• W4385609404 cites W2593426689 @default.
• W4385609404 cites W2882660557 @default.
• W4385609404 cites W2996937472 @default.
• W4385609404 cites W3005533540 @default.
• W4385609404 cites W3015421350 @default.
• W4385609404 cites W3136748212 @default.
• W4385609404 cites W3165245724 @default.
• W4385609404 cites W4312128028 @default.
• W4385609404 cites W49358148 @default.
• W4385609404 doi "https://doi.org/10.1097/md.0000000000034496" @default.
• W4385609404 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37543781" @default.
• W4385609404 hasPublicationYear "2023" @default.
• W4385609404 type Work @default.
• W4385609404 citedByCount "0" @default.
• W4385609404 crossrefType "journal-article" @default.
• W4385609404 hasAuthorship W4385609404A5002223340 @default.
• W4385609404 hasAuthorship W4385609404A5005294787 @default.
• W4385609404 hasAuthorship W4385609404A5016856595 @default.
• W4385609404 hasAuthorship W4385609404A5024283778 @default.
• W4385609404 hasAuthorship W4385609404A5025777565 @default.
• W4385609404 hasAuthorship W4385609404A5034735808 @default.
• W4385609404 hasAuthorship W4385609404A5069469064 @default.
• W4385609404 hasBestOaLocation W43856094041 @default.
• W4385609404 hasConcept C126322002 @default.
• W4385609404 hasConcept C142724271 @default.
• W4385609404 hasConcept C168563851 @default.
• W4385609404 hasConcept C197934379 @default.
• W4385609404 hasConcept C204787440 @default.
• W4385609404 hasConcept C27081682 @default.
• W4385609404 hasConcept C2776478404 @default.
• W4385609404 hasConcept C2777416354 @default.
• W4385609404 hasConcept C2778826759 @default.
• W4385609404 hasConcept C2779234561 @default.
• W4385609404 hasConcept C2779522080 @default.
• W4385609404 hasConcept C2781418897 @default.
• W4385609404 hasConcept C29456083 @default.
• W4385609404 hasConcept C54355233 @default.
• W4385609404 hasConcept C71924100 @default.
• W4385609404 hasConcept C86803240 @default.
• W4385609404 hasConceptScore W4385609404C126322002 @default.
• W4385609404 hasConceptScore W4385609404C142724271 @default.
• W4385609404 hasConceptScore W4385609404C168563851 @default.
• W4385609404 hasConceptScore W4385609404C197934379 @default.
• W4385609404 hasConceptScore W4385609404C204787440 @default.
• W4385609404 hasConceptScore W4385609404C27081682 @default.
• W4385609404 hasConceptScore W4385609404C2776478404 @default.
• W4385609404 hasConceptScore W4385609404C2777416354 @default.
• W4385609404 hasConceptScore W4385609404C2778826759 @default.
• W4385609404 hasConceptScore W4385609404C2779234561 @default.
• W4385609404 hasConceptScore W4385609404C2779522080 @default.
• W4385609404 hasConceptScore W4385609404C2781418897 @default.
• W4385609404 hasConceptScore W4385609404C29456083 @default.
• W4385609404 hasConceptScore W4385609404C54355233 @default.
• W4385609404 hasConceptScore W4385609404C71924100 @default.
• W4385609404 hasConceptScore W4385609404C86803240 @default.
• W4385609404 hasIssue "31" @default.
• W4385609404 hasLocation W43856094041 @default.
• W4385609404 hasLocation W43856094042 @default.
• W4385609404 hasLocation W43856094043 @default.
• W4385609404 hasOpenAccess W4385609404 @default.

• next